MDIT — Medite Cancer Diagnostics Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $6.62m
- $6.81m
Annual cashflow statement for Medite Cancer Diagnostics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2013 December 31st | 2014 December 31st | 2015 December 31st | 2016 December 31st | 2017 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 0.054 | -0.699 | -0.859 | -2.16 | -6.81 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0 | 0.002 | 0 | 0.729 | 1.55 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.627 | -0.444 | 0.216 | 0.129 | 1.89 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -0.404 | -0.891 | -0.388 | -1.09 | -3.57 |
| Capital Expenditures | -0.095 | -0.463 | -0.354 | -0.115 | -0.134 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | 0.001 | 0 | — | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.095 | -0.462 | -0.354 | -0.115 | -0.134 |
| Financing Cash Flow Items | -0.21 | -0.305 | -0.07 | — | -0.417 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.434 | 1.7 | 1.71 | 0.7 | 3.46 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.01 | 0.155 | 0.357 | -0.479 | -0.035 |